Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 20;29(24):6008.
doi: 10.3390/molecules29246008.

Efficient Encapsulation and Controlled Release of the Pesticide Emamectin Benzoate in Polylactic Acid Microspheres Prepared by Modified Solvent Evaporation

Affiliations

Efficient Encapsulation and Controlled Release of the Pesticide Emamectin Benzoate in Polylactic Acid Microspheres Prepared by Modified Solvent Evaporation

Sheng Xu et al. Molecules. .

Abstract

Emamectin benzoate (EB) is a highly effective broad-spectrum insecticide and acaricide. However, because EB is easily degraded, the conventional formulations of EB are often overapplied. In this study, polylactic acid (PLA)-based microspheres were prepared using the modified solvent evaporation method for the controlled release of EB. The microspheres were optimized to achieve higher EB loading. The effects of process parameters on the properties of microspheres, including encapsulation efficiency (EE), particle size, and pesticide loading, were investigated. Additionally, the controlled release behavior of EB microspheres was compared with that of conventional EB emulsifiable concentrate (EC). Spherical-shaped microspheres were obtained with an EE reaching 90.63 ± 1.90%, and introducing an external aqueous phase into the system can significantly enhance the EE of microspheres by over 30%. FTIR, DSC, and XRD analyses indicate that the preparation process of PLA microspheres was mainly physical encapsulation and had no chemical effect on EB. Notably, the EB microspheres displayed more potent control efficacy compared to commercial formulation EB EC against Plutella xylostella. The corrected mortality for the EB microspheres reached 90.00 ± 5.77% after 21 days of application, whereas the corrected mortality for the EB EC was only 19.23 ± 6.66% after 14 days of application. Our study demonstrates that EB-encapsulated PLA microspheres have strong potential as environmentally friendly control release EB formulations.

Keywords: controlled release; emamectin benzoate; microspheres; modified solvent evaporation; polylactic acid.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analysis, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
Effect of gelatin concentration on the EE (a) and particle size (b) of microspheres. Note: These microspheres were prepared without the external aqueous phase. Different lower-case letters indicate significant differences (p < 0.05).
Figure 2
Figure 2
Effect of shearing time on the EE (a) and particle size (b) of microspheres. Note: Different lower-case letters indicate significant differences (p < 0.05).
Figure 3
Figure 3
Effect of oil–water volume ratio on the EE (a) and particle size (b) of microspheres. Note: Different lower-case letters indicate significant differences (p < 0.05).
Figure 4
Figure 4
Effect of PLA concentration on the EE (a) and particle size (b) of microspheres. Note: Different lower-case letters indicate significant differences (p < 0.05).
Figure 5
Figure 5
Effect of core–wall ratio on the EE (a) and particle size (b) of microspheres. Note: Different lower-case letters indicate significant differences (p < 0.05).
Figure 6
Figure 6
SEM of microspheres fabricated by different preparation methods (×5000): (a) conventional solvent evaporation; (b) modified solvent evaporation.
Figure 7
Figure 7
FTIR spectra of EB, EB-free PLA microspheres, and EB-encapsulated PLA microspheres.
Figure 8
Figure 8
DSC analysis of EB, EB-free PLA microspheres, and EB-encapsulated PLA microspheres.
Figure 9
Figure 9
XRD patterns of EB, EB-free PLA microspheres, and EB-encapsulated PLA microspheres.

References

    1. Wahba T.F., El-Bassyouni G.T., El-Shamy A.M., Wahba M.N. Nanoinert diatomaceous and emamectin benzoate: Enhancing wheat protection against fall armyworms for sustainable management. S. Afr. J. Bot. 2024;169:413–425. doi: 10.1016/j.sajb.2024.04.046. - DOI
    1. Sharma N., Mandal K., Sharma S. Validation of LCMS/MS based method for residual estimation of tolfenpyrad and emamectin benzoate in brinjal and cauliflower and their risk assessment. J. Food Compos. Anal. 2024;136:106803. doi: 10.1016/j.jfca.2024.106803. - DOI
    1. Huang B.B., Zhang S.F., Chen P.H., Wu G. Release and Degradation of Microencapsulated Spinosad and Emamectin Benzoate. Sci. Rep. 2017;7:10864. doi: 10.1038/s41598-017-11419-2. - DOI - PMC - PubMed
    1. Singh M.N., Hemant K.S.Y., Ram M., Shivakumar H.G. Microencapsulation: A promising technique for controlled drug delivery. Res. Pharm. Sci. 2010;5:65–77. - PMC - PubMed
    1. Dubey R., Shami T., Rao K. Microencapsulation technology and applications. Def. Sci. J. 2009;59:82–95.

LinkOut - more resources